Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02
USAabout provides insights into the profitability of commercial propertise and offers up-tp-date stock market news for informed investment decesion.
Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02
Sign in to your account